News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Treatment of depression may suffer -- NZMA


All Health Reporters/Chief Executives/Press Officers

FROM: Dr Pippa MacKay, NZMA Chairman

DATE: November 2, 1999

SUBJECT: Treatment of depression may suffer -- NZMA

Tens of thousands of New Zealanders with depression and anxiety disorders may suffer under a PHARMAC decision to cut subsidies for modern antidepressant drugs, the New Zealand Medical Association says.

"While we understand the need to contain costs, it should not be at the expense of patients (in this case, people suffering from a common mental illness which can be effectively treated with modern medications)," said NZMA Chairman, Dr Pippa MacKay.

PHARMAC intends to list a cheaper brand of fluoxetine (of which Prozac is currently the most popular brand on the market), and reduce the subsidy on a range of modern antidepressants to the same level. Part charges will be incurred if other suppliers do not reduce their prices to meet the new subsidy. Some may choose to withdraw their product from the market.

"This agreement may significantly disrupt access to the newer antidepressants which have considerably improved the treatment of depression and anxiety. It seems to contradict the HFA's strategic emphasis on improving mental health care by restricting access to appropriate and needed treatments," Dr MacKay said.

"These drugs are not identical, and have differing side-effects and levels of tolerability. The NZMA believes it is crucial clinically that a range of modern antidepressants from all classes continue to be available without part charge."

Depression and anxiety disorders are extremely common. A recent Christchurch study found a 20 percent lifetime risk of a clinically significant episode of depression. There is also a body of evidence to suggest that the effective treatment of depression is crucial to decreasing New Zealand's high suicide rate.

"In a problem of this magnitude, patients must have access to a range of effective modern treatments," Dr MacKay said. "This plan curtails patient and clinician choice, cuts across quality care and creates barriers to appropriate medications. We would urge PHARMAC to re-examine its plans to ensure that appropriate antidepressants are available to those who need them."


Shani Naylor

Communications Co-ordinator

New Zealand Medical Association

Ph 04 472 4741, 025 284 1081

© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


2021: NZ To Host Women’s Rugby World Cup

New Zealand’s successful bid to host the 2021 Women’s Rugby World Cup will raise the profile of the game locally and provide a valuable economic boost for the game, Minister for Sport and Recreation Grant Robertson says. More>>


Max Rashbrooke Review: Mahler 7 - NZSO

Gustav Mahler’s Seventh Symphony may be one of the least well-known of its ilk, but Edo de Waart and the New Zealand Symphony Orchestra made a compelling case for a reassessment. They showed us a work of immense variety, surprising contrast and delicate shades of light and dark. More>>

Howard Davis Review: Strange Overtones - David Byrne's American Utopia Tour

Scotch-born singer-songwriter David Byrne starts each show on his latest world tour stroking a pink brain as he sits alone at a table in a gray three-button Kenzo suit singing a song called Here from his latest album American Utopia. More>>

Governor-General's Speech: Armistice Day 100 Years On

The response was more muted amongst our soldiers at the Front. Many received the news quietly... There was no cheering. The chaps didn’t get excited. It was just a matter of relief. We didn’t celebrate at all. More>>


Auckland Fringe Programme: A Celebration Of The Bizarre And Beautiful

Building on a huge 2018 programme that saw 492 creatives take 81 events for ventures around the city for a total of 347 performances, Auckland Fringe returns this summer, running February 19 – March 3, 2019. More>>



  • Wellington
  • Christchurch
  • Auckland